Medicare Enrolled
Dr. Kapisthalam Kumar, MD
Hematology · Trinity, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kumar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kumar? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kumar
Dr. Kapisthalam Kumar is a hematology in Trinity, FL, with 20 years in practice. Based on federal Medicare data, Dr. Kumar performed 55,773 Medicare services across 2,010 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kumar received a total of $23,524 from 88 pharmaceutical and/or device companies across 1092 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kumar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ 55,773 Medicare services$ $23,524 industry payments
Medicare Practice Summary
Medicare Utilization ↗55,773
Medicare services
Bottom 39% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
2,010
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,789 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 32,130 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 10,270 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 3,080 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 1,680 | $19 | $51 |
| Complete blood count (CBC) with differential | 1,426 | $8 | $29 |
| Blood draw (venipuncture) | 1,412 | $8 | $9 |
| Dexamethasone injection (steroid) | 1,072 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 920 | $1 | $28 |
| Office visit, established patient (20-29 min) | 657 | $65 | $239 |
| Injection of additional new drug or substance into vein | 405 | $12 | $61 |
| Office visit, established patient (30-39 min) | 352 | $90 | $339 |
| Drug injection, under skin or into muscle | 282 | $10 | $69 |
| Administration of chemotherapy into vein, 1 hour or less | 271 | $98 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 244 | $22 | $84 |
| Injection, diphenhydramine hcl, up to 50 mg | 203 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 196 | $47 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 136 | $16 | $56 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 125 | $3 | $11 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 107 | $1 | $6 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 94 | $17 | $59 |
| Administration of chemotherapy into vein, each additional hour | 90 | $22 | $79 |
| Administration of additional new drug or substance into vein, 1 hour or less | 85 | $49 | $178 |
| Injection of drug or substance into vein | 81 | $28 | $156 |
| Hospital follow-up visit, moderate complexity | 75 | $60 | $197 |
| Automated urinalysis | 59 | $2 | $8 |
| Red blood count, automated test | 55 | $4 | $10 |
| Administration of additional new drug or substance into vein using push technique | 44 | $42 | $170 |
| Hospital follow-up visit, high complexity | 33 | $92 | $285 |
| Initial hospital admission, high complexity | 32 | $123 | $556 |
| Infusion, normal saline solution , 1000 cc | 31 | $2 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 30 | $25 | $156 |
| Initial hospital admission, moderate complexity | 27 | $103 | $377 |
| New patient office visit, complex (60-74 min) | 23 | $157 | $585 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 16 | $133 | $467 |
| New patient office visit (45-59 min) | 16 | $130 | $453 |
| Office visit, established patient (10-19 min) | 14 | $44 | $147 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
58.8% high complexity
33.4% medium
7.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,524
Total received (2018-2024)
Avg $3,361/year across 7 years
Top 20% in FL for hematology
88
Companies
1,092
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,908 (84.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,063 (13.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$552 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,755
2023$3,856
2022$3,418
2021$2,122
2020$2,367
2019$2,448
2018$5,557
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Spectrum Pharmaceuticals Inc.
$3,063
Novartis Pharmaceuticals Corporation
$1,694
E.R. Squibb & Sons, L.L.C.
$1,458
AstraZeneca Pharmaceuticals LP
$1,012
Janssen Biotech, Inc.
$853
PFIZER INC.
$827
Celgene Corporation
$769
Lilly USA, LLC
$764
Genentech USA, Inc.
$743
Daiichi Sankyo Inc.
$605
Seagen Inc.
$599
Merck Sharp & Dohme Corporation
$596
Incyte Corporation
$584
Merck Sharp & Dohme LLC
$575
Gilead Sciences, Inc.
$567
GENZYME CORPORATION
$557
Astellas Pharma US Inc
$515
Amgen Inc.
$508
Bayer HealthCare Pharmaceuticals Inc.
$469
GlaxoSmithKline, LLC.
$402
Kite Pharma, Inc.
$366
Eisai Inc.
$322
ARRAY BIOPHARMA INC
$291
Takeda Pharmaceuticals U.S.A., Inc.
$262
Mirati Therapeutics, Inc.
$254
Regeneron Healthcare Solutions, Inc.
$228
JAZZ PHARMACEUTICALS INC.
$219
AVEO Pharmaceuticals, Inc.
$214
Alexion Pharmaceuticals, Inc.
$210
Bayer Healthcare Pharmaceuticals Inc.
$207
ABBVIE INC.
$193
Exelixis Inc.
$178
Seattle Genetics, Inc.
$177
Janssen Pharmaceuticals, Inc
$168
Pharmacyclics LLC, An AbbVie Company
$150
EMD Serono, Inc.
$145
Taiho Oncology, Inc.
$138
Boehringer Ingelheim Pharmaceuticals, Inc.
$136
Immunomedics, Inc.
$133
Puma Biotechnology, Inc.
$125
PUMA BIOTECHNOLOGY, INC.
$122
BeiGene USA, Inc.
$116
Tempus AI, Inc
$102
Agios Pharmaceuticals, Inc.
$94
Pharmacosmos Therapeutics Inc.
$88
TESARO, Inc.
$85
Ipsen Biopharmaceuticals, Inc
$81
AMAG Pharmaceuticals, Inc.
$77
SERVIER PHARMACEUTICALS LLC
$75
EISAI INC.
$65
Sumitomo Pharma America, Inc.
$63
Myovant Sciences Inc.
$61
MEDIVATION FIELD SOLUTIONS LLC
$58
G1 Therapeutics, Inc.
$58
Rigel Pharmaceuticals, Inc.
$58
AbbVie, Inc.
$55
Global Blood Therapeutics, Inc.
$53
MorphoSys, US Inc.
$53
Karyopharm Therapeutics Inc.
$52
Servier Pharmaceuticals LLC
$51
Medtronic, Inc.
$51
Octapharma USA, Inc.
$50
Blueprint Medicines Corporation
$49
Myriad Genetic Laboratories, Inc.
$47
Advanced Accelerator Applications
$42
GE HealthCare
$40
PharmaEssentia USA Corporation
$40
Janssen Scientific Affairs, LLC
$38
SOBI, INC
$35
Stemline Therapeutics Inc.
$33
Foundation Medicine, Inc.
$32
Helsinn Therapeutics (U.S.), Inc.
$31
Heron Therapeutics, Inc.
$27
TerSera Therapeutics LLC
$26
Clovis Oncology, Inc.
$23
ImmunoGen, Inc.
$22
Genmab U.S., Inc.
$20
EUSA Pharma (US) LLC
$19
Epizyme, Inc.,
$18
PORTOLA PHARMACEUTICALS, INC.
$18
Apellis Pharmaceuticals, Inc.
$17
CTI BioPharma Corp.
$16
Novocure Inc.
$15
Innate Pharma, Inc
$15
TAIHO ONCOLOGY, INC.
$15
Deciphera Pharmaceuticals Inc.
$15
Secura Bio, Inc.
$14
ADC Therapeutics America, Inc.
$13
Top 3 companies account for 26.4% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BESREMI · BEVYXXA · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CEREZYME · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELIQUIS · ELITEK · EMEND · EMPRINT · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Itovebi · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Perjeta · Pomalyst · PreciseTumor · Prolia · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · Stivarga · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zevalin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $42 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
41
Per 100K population
7.0
County median income
$67,384
Nearest hospital
HCA FLORIDA TRINITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kumar is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 20%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kumar experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Kumar performed 32,130 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kumar receive payments from pharmaceutical companies?
Yes. Dr. Kumar received a total of $23,524 from 88 companies across 1,092 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kumar's costs compare to other hematologys in Trinity?
Dr. Kumar's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kumar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Trinity
Browse hematologys in Trinity ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Spectrum Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Spectrum Pharmaceuticals Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology